Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial

Article English OPEN
Lees, K.R.; Davalos, A.; Davis, S.M.; Diener, H.-C.; Grotta, J.; Lyden, P.; Shuaib, A.; Ashwood, T.; Hardemark, H.G.; Wasiewski, W.; Emeribe, U.; Zivin, J.A.;
  • Publisher: American Heart Association

<p><b>Background and Purpose:</b> NXY-059 is a free radical-trapping neuroprotectant demonstrated to reduce disability from ischemic stroke. We conducted analyses on additional end points and sensitivity analyses to confirm our findings.</p>\ud \ud <p><b>Methods:</b> We... View more
Share - Bookmark